These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31809860)

  • 21. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
    Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development - Part II.
    Meruva S; Thool P; Karki S; Bowen W; Ghosh I; Kumar S
    Int J Pharm; 2019 Sep; 568():118509. PubMed ID: 31301463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of various processes for simultaneous complexation and granulation to incorporate drug-cyclodextrin complexes into solid dosage forms.
    Gyanani V; Siddalingappa B; Betageri GV
    Drug Dev Ind Pharm; 2015; 41(11):1856-63. PubMed ID: 25754112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
    Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
    Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of extended dwell time during pre- and main compression on the properties of ibuprofen tablets.
    Peeters E; Silva AFT; Fonteyne M; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2018 Jul; 128():300-315. PubMed ID: 29733949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Drug Release Testing to Evaluate the Retention of Abuse-Deterrent Properties of Polyethylene Oxide Matrix Tablets.
    Meruva S; Rezaei L; Thool P; Donovan MD
    AAPS PharmSciTech; 2020 Oct; 21(7):270. PubMed ID: 33025237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.
    Lavan M; Wang X; McCain R; Jannasch A; Cooper B; Hostetler S; Byrn S; Knipp G
    AAPS PharmSciTech; 2021 Jan; 22(1):40. PubMed ID: 33417081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
    Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.